DK3140317T3 - Peptid-induceret nk-celleaktivering - Google Patents

Peptid-induceret nk-celleaktivering Download PDF

Info

Publication number
DK3140317T3
DK3140317T3 DK15722574.9T DK15722574T DK3140317T3 DK 3140317 T3 DK3140317 T3 DK 3140317T3 DK 15722574 T DK15722574 T DK 15722574T DK 3140317 T3 DK3140317 T3 DK 3140317T3
Authority
DK
Denmark
Prior art keywords
peptide
induced
cell activation
activation
cell
Prior art date
Application number
DK15722574.9T
Other languages
English (en)
Inventor
Salim Iqbal Khakoo
Original Assignee
Univ Southampton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1408264.8A external-priority patent/GB201408264D0/en
Priority claimed from GB201502122A external-priority patent/GB201502122D0/en
Application filed by Univ Southampton filed Critical Univ Southampton
Application granted granted Critical
Publication of DK3140317T3 publication Critical patent/DK3140317T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/70539MHC-molecules, e.g. HLA-molecules
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0646Natural killers cells [NK], NKT cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998Proteins not provided for elsewhere
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DK15722574.9T 2014-05-09 2015-05-08 Peptid-induceret nk-celleaktivering DK3140317T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1408264.8A GB201408264D0 (en) 2014-05-09 2014-05-09 Peptide-induced NK cell activation
GB201502122A GB201502122D0 (en) 2015-02-09 2015-02-09 Peptide-induced NK cell activation
PCT/GB2015/051370 WO2015170123A2 (en) 2014-05-09 2015-05-08 Peptide-induced nk cell activation

Publications (1)

Publication Number Publication Date
DK3140317T3 true DK3140317T3 (da) 2020-07-20

Family

ID=53177692

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15722574.9T DK3140317T3 (da) 2014-05-09 2015-05-08 Peptid-induceret nk-celleaktivering

Country Status (5)

Country Link
US (1) US10995116B2 (da)
EP (1) EP3140317B1 (da)
DK (1) DK3140317T3 (da)
ES (1) ES2805047T3 (da)
WO (1) WO2015170123A2 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201519800D0 (en) * 2015-11-10 2015-12-23 Univ Southampton Peptide-induced nk cell activation
GB201903877D0 (en) 2019-03-21 2019-05-08 Univ Southampton Peptide-induced nk cell activation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2685270C (en) * 1998-05-13 2014-07-29 Pharmexa Inc. Expression vectors for stimulating an immune response and methods of using the same
AU6226100A (en) * 1999-07-19 2001-04-24 Epimmune, Inc. Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions
EP1911461B1 (en) 2000-10-19 2011-12-07 Epimmune Inc. HLA class I and II binding peptides and their uses
EP2402026A3 (en) 2002-09-13 2012-04-18 Intercell AG Method for isolating hepatitis C virus peptides
US20080249283A1 (en) 2004-04-30 2008-10-09 Tomoya Miyakawa Hla-Binding Peptides, Precursors Thereof, Dna Fragments and Recombinant Vectors that Code for Those Peptide Sequences
JP2008509654A (ja) 2004-06-01 2008-04-03 イノジェネティックス・ナムローゼ・フェンノートシャップ C型肝炎ウイルスに対するctlおよび/またはhtl応答を誘導するためのペプチド
EP1652858A1 (en) 2004-10-28 2006-05-03 Innogenetics N.V. Peptides for inducing a CTL and/or HTL response to hepatitis C virus

Also Published As

Publication number Publication date
WO2015170123A3 (en) 2016-02-04
EP3140317B1 (en) 2020-04-15
WO2015170123A2 (en) 2015-11-12
US10995116B2 (en) 2021-05-04
ES2805047T3 (es) 2021-02-10
US20170137466A1 (en) 2017-05-18
EP3140317A2 (en) 2017-03-15

Similar Documents

Publication Publication Date Title
CL2014002755S1 (es) Vehiculo
DK3110442T3 (da) Modificerede meningokok-fhbp-polypeptider
DK3029959T3 (da) Antenneenhed
DK3099791T3 (da) Protein
BR112017000035A2 (pt) conjunto de compartimento de articulação
DK3099793T3 (da) Protein
DK3498588T3 (da) Holdearrangement
DE102014000623A8 (de) Halbhohlnietelement
DK3140317T3 (da) Peptid-induceret nk-celleaktivering
GB201519800D0 (en) Peptide-induced nk cell activation
DK3001076T3 (da) Tilbageløbsforhindrer
ES1100207Y (es) Válvula de alimentación
GB201408264D0 (en) Peptide-induced NK cell activation
GB201502122D0 (en) Peptide-induced NK cell activation
UA32044S (uk) Чохол
DE112015004618A5 (de) Garnitur
TH1401006762B (th) เครื่องหั่น
TH1401006763B (th) เครื่องหั่น
TH1601003330A (th) เซลล์หุ่นยนต์
DK3125735T3 (da) Holderarrangement
FI10657U1 (fi) Veitsi
TH1401005100B (th) พนักพิงหลัง
UA28862S (uk) Бахіла
UA30137S (uk) Підлокітник
TH1601000676A (th) เพพไทด์